P&G Should Clean Up Vicks Early Defense Hand Sanitizer Claims, Labels – FDA
This article was originally published in The Rose Sheet
Product claims and labeling for Procter & Gamble's Vicks Early Defense Foaming Hand Sanitizer are not permitted under FDA's tentative final monographs for OTC health care and first-aid antiseptics, according to the agency
You may also be interested in...
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
When businesses rapidly pivot to offering consumer health products and services, they’re likely not contemplating compliance with FDA regulations. Recent warning letters are more proof COVID-19 represents opportunities for numerous businesses that aren’t prepared to follow or simply aren’t aware of FDA regulations.
Latest warning to Humaworm notes findings that FDA inspectors made in July 2019. FDA officials apparently have been in Humaworm’s facility since then, executing a search warrant in October and confiscating encapsulating machines, herbs, capsules, computers, and records.